- Home
- CAPR vs TIXT Comparison
CAPR vs TIXT Comparison
Compare CAPR & TIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- TIXT
- Stock Information
- Founded
- CAPR 2005
- TIXT 2005
- Country
- CAPR United States
- TIXT Canada
- Employees
- CAPR N/A
- TIXT N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- TIXT EDP Services
- Sector
- CAPR Health Care
- TIXT Technology
- Exchange
- CAPR Nasdaq
- TIXT Nasdaq
- Market Cap
- CAPR 867.6M
- TIXT 1.0B
- IPO Year
- CAPR N/A
- TIXT 2021
- Fundamental
- Price
- CAPR $13.07
- TIXT $3.61
- Analyst Decision
- CAPR Strong Buy
- TIXT Hold
- Analyst Count
- CAPR 7
- TIXT 9
- Target Price
- CAPR $39.29
- TIXT $5.78
- AVG Volume (30 Days)
- CAPR 1.8M
- TIXT 326.1K
- Earning Date
- CAPR 11-13-2024
- TIXT 02-07-2025
- Dividend Yield
- CAPR N/A
- TIXT N/A
- EPS Growth
- CAPR N/A
- TIXT N/A
- EPS
- CAPR N/A
- TIXT N/A
- Revenue
- CAPR $23,228,045.00
- TIXT $2,659,000,000.00
- Revenue This Year
- CAPR N/A
- TIXT N/A
- Revenue Next Year
- CAPR $74.85
- TIXT $2.16
- P/E Ratio
- CAPR N/A
- TIXT $32.34
- Revenue Growth
- CAPR 65.33
- TIXT 0.49
- 52 Week Low
- CAPR $3.52
- TIXT $2.83
- 52 Week High
- CAPR $23.40
- TIXT $11.51
- Technical
- Relative Strength Index (RSI)
- CAPR 37.42
- TIXT 43.06
- Support Level
- CAPR $12.25
- TIXT $3.46
- Resistance Level
- CAPR $20.75
- TIXT $3.86
- Average True Range (ATR)
- CAPR 1.62
- TIXT 0.19
- MACD
- CAPR -0.24
- TIXT -0.04
- Stochastic Oscillator
- CAPR 9.65
- TIXT 23.62
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.